Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Triple Negative Breast Neoplasms 2Colorectal Neoplasms 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pancreatic Neoplasms 1Overweight 1Ovarian Neoplasms 1Obesity 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Leukemia 1Hypothalamic Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1GastroEsophageal Cancer 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Burkitt Lymphoma 1Breast Carcinoma In Situ 1Advanced Malignant Solid Neoplasm 1

Interventions

Specimen Handling 2Methods 2Educational Status 2Early Intervention, Educational 2spartalizumab 1siltuximab 1Palliative Care 1Nutrition Assessment 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Diet Therapy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Malignant Solid Neoplasm × Diet Therapy × Clear all
NCT06438588 2026-05-22

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Mayo Clinic

Phase NA Recruiting
10 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡